Sequana Medical Future Growth

Future criteria checks 2/6

Sequana Medical is forecast to grow earnings and revenue by 47.4% and 65.3% per annum respectively while EPS is expected to grow by 45.4% per annum.

Key information

47.4%

Earnings growth rate

45.4%

EPS growth rate

Medical Equipment earnings growth18.7%
Revenue growth rate65.3%
Future return on equityn/a
Analyst coverage

Low

Last updated25 Mar 2024

Recent future growth updates

Recent updates

Health Check: How Prudently Does Sequana Medical (EBR:SEQUA) Use Debt?

Mar 19
Health Check: How Prudently Does Sequana Medical (EBR:SEQUA) Use Debt?

Did Sequana Medical's (EBR:SEQUA) Share Price Deserve to Gain 51%?

Jan 26
Did Sequana Medical's (EBR:SEQUA) Share Price Deserve to Gain 51%?

Do Institutions Own Sequana Medical NV (EBR:SEQUA) Shares?

Dec 03
Do Institutions Own Sequana Medical NV (EBR:SEQUA) Shares?

Earnings and Revenue Growth Forecasts

ENXTBR:SEQUA - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202623-6N/A-51
12/31/202531-1N/A-51
12/31/20241-24-35-243
12/31/20231-32-22-263
6/30/20231-32-30-30N/A
3/31/20231-32-29-29N/A
12/31/20221-31-28-27N/A
9/30/20221-29-27-26N/A
6/30/20221-27-26-25N/A
3/31/20221-25-25-25N/A
12/31/20210-24-24-24N/A
9/30/20210-23-22-22N/A
6/30/20210-21-20-20N/A
3/31/20211-20-18-18N/A
12/31/20201-19-17-17N/A
9/30/20201-18-16-16N/A
6/30/20201-17-16-16N/A
3/31/20201-16-17-17N/A
12/31/20191-15-19-18N/A
9/30/20191-16-19-19N/A
6/30/20191-16-18-18N/A
3/31/20191-15-14-14N/A
12/31/20181-14-10-10N/A
9/30/20181-10-8-8N/A
12/31/20171-8-8-8N/A
12/31/20161-14N/A-13N/A
12/31/20152-12N/A-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SEQUA is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SEQUA is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SEQUA is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SEQUA's revenue (65.3% per year) is forecast to grow faster than the Belgian market (5.8% per year).

High Growth Revenue: SEQUA's revenue (65.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SEQUA's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.